Population screening by faecal occult blood testing has been shown to detect greater than three times the annual incidence of colorectal cancer , the pathological stage of those cancers detected by screening being more favourable (75% Dukes' Stage A) than those in an age/sex matched control group.
Guaiac impregnated slide tests for faecal occult blood may produce false positive results from reaction with either animal haemoglobin or vegetable peroxidase (Ostrow et al., 1973; , and false negative tests may result from cancers or adenomas bleeding only intermittently or at a level below the sensitivity of the test (Doran & Hardcastle, 1982; . A low sensitivity test such as Haemoccult (Eaton Laboratories) results in a low false positive but high false negative rate ) whilst a sensitive test such as Fecatest (Nordic Pharmaceuticals) has a false positive rate which is unacceptably high when subjects are on an unrestricted diet (Beretta et al., 1978) .
Immunological tests specific for human haemoglobin should overcome both of these problems as the sensitivity can be adjusted and there is no cross reaction with animal haemoglobin or vegetable peroxidase. Several such tests have been described, using different immunological methods, such as radial immunodiffusion (Barrows et al., 1978; Williams et al., 1982) , immunofluorescence (Vellacott et al., 1981) and an enzyme-linked immunoassay (ELISA) (Turunen et al., 1984) .
The ELISA test has recently been combined with a sensitive guaiac test, Fecatwin Sensitive/Feca EIA (Turunen et al., 1984) . This test has been used to screen an asymptomatic population and compared with Haemoccult, the guaiac test most extensively used in screening studies for colorectal cancer , Farrands et al., 1981 , Winawer et al., 1980 , the yield and workload generated by both tests being investigated.
Patients and methods
Six thousand four hundred and fifty individuals between the ages of 45-75 were identified from general practitioners' records in three general practices in the Nottingham area. Those with known large bowel disease and those considered unsuitable by the family doctor were excluded. The remaining subjects were randomly allocated by household to either test or control group. Table T . On one run the blank values were unexpectedly high. The patients investigated on the basis of this day's testing have been included since one cancer was detected but the values are not included in Table I .
The response and positivity rate for the tests can (Table TI) . Examination of the subjects with a positive test yielded neoplastic disease in 32 individuals. Five carcinomas were identified (3.8 per 1,000 persons screened); 4 were Dukes' Stage A and one Dukes' Stage C. Two of the carcinomas were situated in the rectum and one in the sigmoid colon; two were invasive carcinoma in sessile adenomas in the rectosigmoid. Thirty-seven adenomas were identified in 29 patients; four of these were greater in diameter than 2 cm, 19 between 1 and 2 cm and 14 smaller than 1 cm. Histology showed two to be villous adenomas, 13 to be tubulo-villous and 18 to be tubular (4 polyps were not retrieved at endoscopy). The degree of cellular dysplasia was moderate in 15 and severe in 6.
The yields of Haemoccult, Fecatwin Sensitive and Feca EIA tests for neoplastic disease are as shown in Table TT Figure 1 Response of asymptomatic individuals offered faecal occult blood testing. In the Haemoccult positive subjects, 7 were found to have a recognisable non-neoplastic cause for bleeding and in only 9 was no cause for bleeding found. In the Feca EIA positive subjects, a non-neoplastic cause for bleeding was found in 24, and 54 were found to have no cause for bleeding. Sixty-five patients completed re-testing and only two were positive of Feca EIA. In these individuals upper gastrointestinal investigations were undertaken. In one an early gastric carcinoma was diagnosed; the other showed changes of gastric metaplasia.
Eight individuals refused investigation and one died between completing the tests and investigation.
Discussion
One thousand three hundred and four (44%) of individuals completed and returned both screening tests. Thus the addition of a second test does not appear to reduce the acceptance of the screening test when compared with Haemoccult alone (42%) . The detection rate for colorectal cancers (3.8 per 1000 persons screened) is similar to that found in a larger study in the Nottingham area using Haemoccult . The detection rate for adenomas, however, has been increased from 8.8 per 1000 to 17.6 per 1000 for adenomas > 1 cm diameter.
If the tests are considered separately, then Fecatwin Sensitive was the most sensitive, correctly identifying all of the carcinomas and 20 of the 23 adenomas > 1 cm diameter. However, the addition of the Feca EIA component reduced the sensitivity of the test and whilst all 5 cancers were detected, only 11 (50%) of the adenomas >1 cm diameter were detected. Haemoccult, on the other hand, missed 2 cancers but detected 20 (87%) adenomas > 1 cm diameter. It is well recognised that Haemoccult has a false negative rate because tumours bleed intermittently and the bleeding may be slight , and the distribution in the stool is not uniform. This can be reduced either by rehydration of the samples or by increasing the number of samples tested . Equally, the use of a more sensitive guaiac test such as Fecatwin Sensitive will give a lower false negative rate but higher false positive rate. Indeed, in this study the overall positivity rate for Fecatwin "S" was over 25%. Many of the false positive results are the result of crossreactions with animal haemoglobin or vegetables peroxidases. The addition of the Feca EIA component should, theoretically, eliminate these false positives. However, a total of 61 (54%) individuals were investigated and no cause for bleeding was found. This may be due to minute traces of haemoglobin in the stool or it may be due to deterioration of the test discs on storage, even at -20°C. Our own observations have indicated that changes occur in the discs which "create" false positive results (Armitage & Hardcastle, unpublished data). A recognisable non-neoplastic cause for bleeding was detected in 8 Haemoccult positive and 24 Feca EIA positive subjects. The number of subjects in whom no bleeding site could identified was only 9 for Haemoccult (24%) but 54 for Feca EIA (52%). The large size of the latter group may be due partly to unreliability of the test discs on storage or the detection of minute amounts of haemoglobin without recognisable cause, since all of the controls for the assay itself appeared satisfactory.
This study has reproduced the detection rate for colorectal cancer and the proportion of early cancers found in the previously reported screening study in the Nottingham area. Feca EIA has increased the yield of neoplastic disease; however, the high false positive rate makes the test in its present form unsuitable for population screening.
As a result of the observations reported here and studies performed on the reliability of the tests under conditions of storage the manufacturers have modified the test so that the "cut off" limit for positivity and the stability on storage are improved.
